Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model med./bio.

Published in: Int J Mol Sci 2022; 23 (22): 14073

Exposure